In a groundbreaking advancement for colorectal cancer treatment, recent data from the Phase III BREAKWATER trial heralds a new era...

In the relentless quest to unravel the complex biological factors contributing to colorectal cancer, a recent comprehensive meta-analysis sheds new...

In a groundbreaking retrospective study published in BMC Cancer, researchers have unveiled compelling evidence supporting the pivotal role of chemotherapy...

In a groundbreaking nationwide study published in BMC Cancer, researchers have unveiled critical new insights into the real-world epidemiology, management,...

Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B...

In a groundbreaking study poised to transform our understanding of pituitary neuroendocrine tumors (PitNETs), researchers have deployed cutting-edge single-cell and...

A landmark advancement in the treatment of newly diagnosed multiple myeloma patients has emerged from the recently presented ADVANCE clinical...

A groundbreaking study led by researchers at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School...

In the evolving landscape of adolescent and young adult (AYA) oncology care, a groundbreaking study out of the University of...

A groundbreaking study led by researchers at the University of Cincinnati Cancer Center has unveiled novel insights into the intricate...